Korea lags in research spending for development of anticancer drugs
Published: 2010-04-08 06:58:00
Updated: 2010-04-08 06:58:00
Korea has lagged behind Japan and other developed nations in research and development (R&D) activities over the development of anticancer agents, undermining present and future growth potential, a local professor said in a recent forum organized by the Health Ministry
“It’s true Korea has incr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.